Our centers of expertise span therapeutic areas, markets and geographies, and are underpinned by these four core research principles:
Download this summary report to find out about therapies in clinical development, efficacy rates, and unmet needs for on Alzheimer’s disease.
Download this summary report to find out about therapies in clinical development, efficacy rates and unmet needs for Amyotrophic Lateral Sclerosis.
Associate Director Jasdeep Mann, and Senior Analyst Kankanala Thulasai, have produced a summary of the emerging treatment landscape for obesity.
Learn about therapies in clinical development, efficacy rates, unmet needs, and future opportunities for pharmaceutical companies in the NASH space.
Download the summary report to find out about therapies in clinical development for myasthenia gravis, efficacy rates, unmet needs, and opportunities
Jasdeep Mann and Kankanala Thulasai, have produced a summary of the emerging treatment landscape for Crohn's disease.
Jasdeep Mann, and Kankanala Thulasai, have produced a summary of the emerging treatment landscape for ulcerative colitis
The report is an excerpt of our ethnographic research of oncology patients in the UK with head and neck and gastric cancer.
Download this report to learn about HCP and patient insights, the key benefits and challenges of telemedicine.
An interactive collection of case studies that outline how we effectively apply the principles of behavioral science in healthcare market research.
Download this report to find answers to the new business questions around digital health.
We recently caught up with Dr Xavier Tello, to get an update on the status of these reforms and explore their implications for the pharma industry.
Rapport is our monthly newsletter where we share our latest expertise and experience.
